AI-platform connecting clinical trials with suitable sites and patients, improving trial efficiency and accessibility

Inato is a global health-tech company matching clinical trials with qualified sites worldwide and optimizing site performance throughout the trial. The company extends its reach globally, with a notable focus on the U.S., where it helps pharmaceutical groups (“sponsors”) and Contract Research Organization (CRO) (i) identify high-performing research sites, (ii) increase the pool of available patients, and (iii) deliver efficient, timely studies. Inato makes trials more accessible, efficient and inclusive by freely enabling community sites to select the right opportunities for the sponsor.

Funds
La Maison NextGen
Company
Inato
Investment date
2023
Strategy
Venture capital
Status
Active
Sector
Health
World region
France